Familial neuroendocrine tumor syndromes: from genetics to clinical practice.

Abstract excerpt

Thanks to recent developments in molecular biology and cancer genetics, genetic testing has become widely available and useful in several kinds of familial tumor syndrome. However, the impact of genetic testing on medical management is not always straightforward. Clinicians have to consider the psychological impact and ethical complexities of communicating hereditary cancer risk information to families. This...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cost of Illness
• Share to Gene Expression Regulation, Neoplastic
• Share to Genetic Counseling